The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting

Summary

The goal of this clinical research study is to learn if it is tolerable for patients with NSCLC to receive afatinib before surgery. The safety of this drug will also be studied.

Timeline

Start

2015-07-01

Primary completion

2017-08-16

Completion

2017-08-16

Drugs

Indications